4//SEC Filing
Silva Francisco 4
Accession 0001567619-23-003891
CIK 0001505497other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:26 AM ET
Size
19.8 KB
Accession
0001567619-23-003891
Insider Transaction Report
Form 4
Silva Francisco
VP of Research and Development
Transactions
- Tax Payment
Common Stock
2023-02-18$2.99/sh−374$1,118→ 165,672 total
Holdings
- 12,136(indirect: By IRA)
Common Stock
- 1
Stock Option
Exercise: $3000.00Exp: 2023-10-04→ Common Stock (1 underlying) - 3
Stock Option
Exercise: $3000.00Exp: 2024-02-18→ Common Stock (3 underlying) - 1
Stock Option
Exercise: $3000.00From: 2014-03-12Exp: 2024-03-11→ Common Stock (1 underlying) - 9
Stock Option
Exercise: $3000.00Exp: 2024-10-23→ Common Stock (9 underlying) - 6
Stock Option
Exercise: $3000.00Exp: 2025-09-04→ Common Stock (6 underlying) - 15
Stock Option
Exercise: $3000.00Exp: 2026-06-10→ Common Stock (15 underlying) - 20
Stock Option
Exercise: $3000.00Exp: 2027-07-12→ Common Stock (20 underlying) - 25
Stock Option
Exercise: $3000.00Exp: 2028-10-29→ Common Stock (25 underlying) - 293,479
Stock Option
Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying) - 42,059
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying) - 106,762
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (106,762 underlying)
Footnotes (6)
- [F1]Shares were withheld from vested stock grant to pay the associated withholding taxes.
- [F2]Includes 98,862 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
- [F3]The option is currently exercisable.
- [F4]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
- [F5]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.
- [F6]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 with the remaining 53,381 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
Documents
Issuer
BioRestorative Therapies, Inc.
CIK 0001505497
Entity typeother
Related Parties
1- filerCIK 0001527241
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:26 AM ET
- Size
- 19.8 KB